Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Oleuropein, the Main Polyphenol of Olea europaea Leaf Extract, Has an Anti-Cancer Effect on Human BRAF Melanoma Cells and Potentiates the Cytotoxicity of Current Chemotherapies.

Ruzzolini J, Peppicelli S, Andreucci E, Bianchini F, Scardigli A, Romani A, la Marca G, Nediani C, Calorini L.

Nutrients. 2018 Dec 8;10(12). pii: E1950. doi: 10.3390/nu10121950.

2.

The economic burden of multidrug-resistant tuberculosis.

Caminero JA, Scardigli A.

Int J Tuberc Lung Dis. 2018 Aug 1;22(8):831-832. doi: 10.5588/ijtld.18.0408. No abstract available.

PMID:
29991388
3.

Leishmanicidal activity of green tea leaves and pomegranate peel extracts on L. infantum.

Imperatori F, Barlozzari G, Scardigli A, Romani A, Macrì G, Polinori N, Bernini R, Santi L.

Nat Prod Res. 2018 Jun 4:1-7. doi: 10.1080/14786419.2018.1481841. [Epub ahead of print]

PMID:
29863902
4.

Bedaquiline: how better to use it.

Caminero JA, Piubello A, Scardigli A, Migliori GB.

Eur Respir J. 2017 Nov 9;50(5). pii: 1701670. doi: 10.1183/13993003.01670-2017. Print 2017 Nov. No abstract available.

5.

Proposal for a standardised treatment regimen to manage pre- and extensively drug-resistant tuberculosis cases.

Caminero JA, Piubello A, Scardigli A, Migliori GB.

Eur Respir J. 2017 Jul 5;50(1). pii: 1700648. doi: 10.1183/13993003.00648-2017. Print 2017 Jul. No abstract available.

6.

Investing in a novel shorter treatment regimen for multidrug-resistant tuberculosis: to be repeated.

Yassin MA, Jaramillo E, Wandwalo E, Falzon D, Scardigli A, Kunii O, Weyer K.

Eur Respir J. 2017 Mar 22;49(3). pii: 1700081. doi: 10.1183/13993003.00081-2017. Print 2017 Mar. No abstract available.

7.

Classification of drugs to treat multidrug-resistant tuberculosis (MDR-TB): evidence and perspectives.

Rendon A, Tiberi S, Scardigli A, D'Ambrosio L, Centis R, Caminero JA, Migliori GB.

J Thorac Dis. 2016 Oct;8(10):2666-2671. No abstract available.

8.

[Tuberculosis in children. Challenges and opportunities].

Caminero JA, Scardigli A.

An Pediatr (Barc). 2016 Dec;85(6):281-283. doi: 10.1016/j.anpedi.2016.09.012. Epub 2016 Nov 4. Spanish. No abstract available.

9.

Classifying new anti-tuberculosis drugs: rationale and future perspectives.

Tiberi S, Scardigli A, Centis R, D'Ambrosio L, Muñoz-Torrico M, Salazar-Lezama MÁ, Spanevello A, Visca D, Zumla A, Migliori GB, Caminero Luna JA.

Int J Infect Dis. 2017 Mar;56:181-184. doi: 10.1016/j.ijid.2016.10.026. Epub 2016 Nov 3.

10.

Global Analysis of Type Three Secretion System and Quorum Sensing Inhibition of Pseudomonas savastanoi by Polyphenols Extracts from Vegetable Residues.

Biancalani C, Cerboneschi M, Tadini-Buoninsegni F, Campo M, Scardigli A, Romani A, Tegli S.

PLoS One. 2016 Sep 26;11(9):e0163357. doi: 10.1371/journal.pone.0163357. eCollection 2016.

11.

Simple and practical measures to reduce tuberculosis transmission in public buildings.

Scardigli A, Caminero JA.

Int J Tuberc Lung Dis. 2016 Sep;20(9):1137-8. doi: 10.5588/ijtld.16.0450. No abstract available.

PMID:
27510232
12.

Efficacy and tolerability of ethionamide versus prothionamide: a systematic review.

Scardigli A, Caminero JA, Sotgiu G, Centis R, D'Ambrosio L, Migliori GB.

Eur Respir J. 2016 Sep;48(3):946-52. doi: 10.1183/13993003.00438-2016. Epub 2016 Jun 10. Review. No abstract available.

13.

Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.

Tiberi S, Sotgiu G, D'Ambrosio L, Centis R, Abdo Arbex M, Alarcon Arrascue E, Alffenaar JW, Caminero JA, Gaga M, Gualano G, Skrahina A, Solovic I, Sulis G, Tadolini M, Alarcon Guizado V, De Lorenzo S, Roby Arias AJ, Scardigli A, Akkerman OW, Aleksa A, Artsukevich J, Auchynka V, Bonini EH, Chong Marín FA, Collahuazo López L, de Vries G, Dore S, Kunst H, Matteelli A, Moschos C, Palmieri F, Papavasileiou A, Payen MC, Piana A, Spanevello A, Vargas Vasquez D, Viggiani P, White V, Zumla A, Migliori GB.

Eur Respir J. 2016 Jun;47(6):1758-66. doi: 10.1183/13993003.00214-2016. Epub 2016 Apr 13.

14.

Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.

Tiberi S, Payen MC, Sotgiu G, D'Ambrosio L, Alarcon Guizado V, Alffenaar JW, Abdo Arbex M, Caminero JA, Centis R, De Lorenzo S, Gaga M, Gualano G, Roby Arias AJ, Scardigli A, Skrahina A, Solovic I, Sulis G, Tadolini M, Akkerman OW, Alarcon Arrascue E, Aleska A, Avchinko V, Bonini EH, Chong Marín FA, Collahuazo López L, de Vries G, Dore S, Kunst H, Matteelli A, Moschos C, Palmieri F, Papavasileiou A, Spanevello A, Vargas Vasquez D, Viggiani P, White V, Zumla A, Migliori GB.

Eur Respir J. 2016 Apr;47(4):1235-43. doi: 10.1183/13993003.02146-2015. Epub 2016 Mar 10.

15.

Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis.

Tiberi S, Sotgiu G, D'Ambrosio L, Centis R, Arbex MA, Alarcon Arrascue E, Alffenaar JW, Caminero JA, Gaga M, Gualano G, Skrahina A, Solovic I, Sulis G, Tadolini M, Alarcon Guizado V, De Lorenzo S, Roby Arias AJ, Scardigli A, Akkerman OW, Aleksa A, Artsukevich J, Avchinko V, Bonini EH, Chong Marín FA, Collahuazo López L, de Vries G, Dore S, Kunst H, Matteelli A, Moschos C, Palmieri F, Papavasileiou A, Payen MC, Piana A, Spanevello A, Vargas Vasquez D, Viggiani P, White V, Zumla A, Migliori GB.

Clin Infect Dis. 2016 May 1;62(9):1188-90. doi: 10.1093/cid/ciw088. Epub 2016 Feb 16. No abstract available.

PMID:
26908794
16.

Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs.

La Torre A, Giupponi G, Duffy D, Conca A, Cai T, Scardigli A.

Pharmacopsychiatry. 2016 Jan;49(1):3-13. doi: 10.1055/s-0035-1565100. Epub 2015 Nov 16. Review.

PMID:
26569417
17.

Classification of antituberculosis drugs: a new proposal based on the most recent evidence.

Caminero JA, Scardigli A.

Eur Respir J. 2015 Oct;46(4):887-93. doi: 10.1183/13993003.00432-2015. No abstract available.

18.

Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.

Lange C, Abubakar I, Alffenaar JW, Bothamley G, Caminero JA, Carvalho AC, Chang KC, Codecasa L, Correia A, Crudu V, Davies P, Dedicoat M, Drobniewski F, Duarte R, Ehlers C, Erkens C, Goletti D, Günther G, Ibraim E, Kampmann B, Kuksa L, de Lange W, van Leth F, van Lunzen J, Matteelli A, Menzies D, Monedero I, Richter E, Rüsch-Gerdes S, Sandgren A, Scardigli A, Skrahina A, Tortoli E, Volchenkov G, Wagner D, van der Werf MJ, Williams B, Yew WW, Zellweger JP, Cirillo DM; TBNET.

Eur Respir J. 2014 Jul;44(1):23-63. doi: 10.1183/09031936.00188313. Epub 2014 Mar 23.

19.

Implementation of tuberculosis infection control measures at HIV care and treatment sites in sub-Saharan Africa.

Reid MJ, Saito S, Nash D, Scardigli A, Casalini C, Howard AA.

Int J Tuberc Lung Dis. 2012 Dec;16(12):1605-12. doi: 10.5588/ijtld.12.0033.

PMID:
23131257
20.

Quality control and analytical test method for Taxus baccata tincture preparation.

Vignolini P, Gehrmann B, Melzig MF, Borsacchi L, Scardigli A, Romani A.

Nat Prod Commun. 2012 Jul;7(7):875-7.

PMID:
22908569
21.

TB diagnostic capacity in sub-Saharan African HIV care settings.

Saito S, Howard AA, Reid MJ, Elul B, Scardigli A, Verkuijl S, Nyaruhirira AU, Nash D.

J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):216-20.

22.

Tuberculosis incidence at the Burundi-Rwanda border 15 years after the civil war.

Guglielmetti L, Cazzadori A, Scardigli A, Valentinotti R, Conti M, Concia E.

Clin Infect Dis. 2012 Jan 1;54(1):155-6. doi: 10.1093/cid/cir779. Epub 2011 Nov 3. No abstract available.

PMID:
22052891
23.

Is the recommendation not to use rifampin plus pyrazinamide for latent tuberculosis treatment always imperative?

Cazzadori A, Allegranzi B, Scardigli A, Favari F, Concia E.

Chest. 2004 Aug;126(2):657-8. No abstract available.

PMID:
15302765
24.

Clinical and demographic aspects of extrathoracic tuberculosis: experience of an Italian university hospital.

Baussano I, Cazzadori A, Scardigli A, Concia E.

Int J Tuberc Lung Dis. 2004 Apr;8(4):486-92.

PMID:
15141743
25.

Staphylococcal sepsis delaying diagnosis and treatment of vertebral tuberculosis.

Baussano I, Cazzadori A, Danzi C, Scardigli A, Concia E.

Scand J Infect Dis. 2003;35(6-7):436. No abstract available.

PMID:
12953968

Supplemental Content

Loading ...
Support Center